Page last updated: 2024-08-22

platinum and Hodgkin Disease

platinum has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Behnia, S; Cassaday, RD; Gopal, AK; Graf, SA; Green, DJ; Holmberg, L; Libby, EN; Maloney, DG; Onishi, M; Pagel, JM; Philip, M; Press, OW; Roden, JE; Schiavo, K; Shustov, AR; Smith, SD; Till, BG1

Other Studies

1 other study(ies) available for platinum and Hodgkin Disease

ArticleYear
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.
    Hematological oncology, 2015, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Brentuximab Vedotin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Platinum; Positron-Emission Tomography; Prognosis; Treatment Outcome; Young Adult

2015